SLC12A2 and brain edema: Jayakumar et al. have previously involved an upregulation of NKCC1 expression in the mediation of astrocyte swelling in vitro [44], [45], and intraperitoneal injection of the NKCC1 inhibitor bumetanide was found to attenuate TAA-induced brain edema [36].